PhD Training Opportunity in Cell and Gene Therapy at Joint Clinical Research Center Uganda
Job Description
The Joint Clinical Research Center (JCRC) is pleased to announce an exceptional PhD training opportunity in Cell and Gene Therapy (CGT) for qualified Ugandan researchers and medical professionals. This prestigious programme aims to build local capacity in cutting-edge medical research and treatment development.
Key Programme Details:
• Advanced training in cell and gene therapy techniques and applications
• Comprehensive research methodology and clinical applications
• Hands-on laboratory experience with modern equipment
• Mentorship from experienced researchers and medical professionals
• Focus on developing treatments relevant to Uganda's healthcare needs
Eligibility Requirements:
• Master's degree in relevant field (Medicine, Biomedical Sciences, Biotechnology)
• Strong academic record and research potential
• Commitment to advancing healthcare in Uganda
• Previous research experience preferred
• Excellent analytical and problem-solving skills
Programme Benefits:
• Fully funded PhD training programme
• Access to state-of-the-art research facilities
• International networking opportunities
• Publication and conference presentation support
• Career development in emerging medical fields
• Contribution to Uganda's healthcare advancement
This training represents a significant opportunity for Ugandan professionals to specialise in one of medicine's most promising fields. Cell and gene therapy has the potential to revolutionise treatment for various conditions prevalent in Uganda, including genetic disorders, cancers, and infectious diseases.
Application Information:
The closing date for applications is Wednesday, 17th September 2025 at 11:59 pm. Interested candidates should download the complete training opportunity details from the JCRC website for comprehensive information about application procedures, selection criteria, and programme structure.
Join JCRC in pioneering medical research that addresses Uganda's unique healthcare challenges while contributing to global scientific knowledge in cell and gene therapy.